טוען...
Training patients for self‐administration of a new subcutaneous C1‐inhibitor concentrate for hereditary angioedema
AIMS: The aim of this study was to provide recommendations for training patients with hereditary angioedema, based on nursing clinical trial experience, to self‐administer subcutaneous C1‐INH (C1‐INH[SC]) used as routine prophylaxis. BACKGROUND: A volume‐reduced, subcutaneous C1‐INH concentrate (C1‐...
שמור ב:
| הוצא לאור ב: | Nurs Open |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6279717/ https://ncbi.nlm.nih.gov/pubmed/30534402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/nop2.194 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|